Skip to content
Read about the groundbreaking cancer research, care, and more happening at the Herbert Irving Comprehensive Cancer Center.
Our researchers are helping to turn the discoveries we make into tomorrow's advanced treatments for our patients.
We work with our communities and patients to remove access barriers to cancer prevention, screening, treatment and survivorship services.
Learn more about the Irving Cancer Drug Discovery Program (ICDDP) at the Herbert Irving Comprehensive Cancer Center.
We're dedicated to developing the next generation of researchers and physicians through cross-disciplinary training and fellowship programs
New research from HICCC members shows that higher blood glucose levels ‘attract’ cancer cells to spread to the liver.
Research from Dr. Ciccia's lab reveals the dual mechanism of SMARCAL1, a DNA translocase, and its potential as a therapeutic target.
Spotlighting new research from the Momen-Heravi lab on immunotherapy response in head and neck cancer and other solid tumor types.
New research by the labs of Nicholas Arpaia, PhD, (pictured) and Tal Danino, PhD, marks a major step forward in efforts to enlist non-pathogenic bacteria to combat cancer.
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.